Watch as unsuspecting travelers find themselves caught in a web of unexpected troubles! 😳 The world of tourism can sometimes lead down bizarre paths, and this surprising twist reveals the hidden ...

The French left-wing papers rejoice after a controversial public broadcasting bill is rejected by parliament. The New York ...

Can taking steroids cause acne Read ahead to know about steroid-induced acne causes symptoms treatment and prevention with ...

So, what does whey protein actually do for women? Well, again, it depends on what you’re doing alongside it. Many women take ...

Young adults in Vietnam are suffering from kidney failure after consuming unregulated weight loss pills and supplements but ...

POTTSVILLE — After 12 years of promoting bodybuilding competitions in the city, Warren Egebo is ready to step down. Egebo, 75, the promoter of the Mr. Anthracite Natural and Mr. Coal Natural ...

Scarlett Johansson and Mahershala Ali play dino-hunting special ops in the seventh "Jurassic Park" entry, now directed by ...

Arslan Ash was unfairly banned from a Tekken 7 tournament for an absurd reason back in 2022. The news only came to light after the International Esports ...

Surrogate end points in oncology: aligning drug development incentives and patient needs Matthew Vogel Rona Yaeger Frank S. David Correspondence 06 Jun 2025 Nature Reviews Clinical Oncology P: 1-2 ...

The drug has already been launched in Australia, Canada, the EU, mainland China, and Japan and, although it was rejected by the US FDA last year, is predicted to make $4.7 billion in sales from G7 ...

Pfizer has joined the ranks of companies developing cancer drugs that target both PD-1 and VEGF – one of the hottest drug classes in oncology, via a $6 billion licensing deal with China's 3SBio.